Annual Report And Financial Statements

Overview

The report presents FY22 as a transition toward commercial rollout of KidneyIntelX, including 28 private insurance and network provider contracts and Medicare payment. Consolidated revenue reached $2.9 million, with the financial statements reporting 2,970 in $'000. The report also sets out CSR commitments covering environmental impacts, employees, community and human rights.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022
Period: Ends 30 June 2022
Publication date: 9 November 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services